Cargando…
Antiviral activity of mitoxantrone dihydrochloride against human herpes simplex virus mediated by suppression of the viral immediate early genes
BACKGROUND: HSV-1 is a common pathogen that infects 50–90% of the human population worldwide. HSV-1 causes numerous infection-related diseases, some of which are severely life-threatening. There are antiviral medications with activity against HSV-1. However, with the emergence of drug-resistant muta...
Autores principales: | Huang, Qiang, Hou, Jue, Yang, Peng, Yan, Jun, Yu, Xiaoliang, Zhuo, Ying, He, Sudan, Xu, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898960/ https://www.ncbi.nlm.nih.gov/pubmed/31812160 http://dx.doi.org/10.1186/s12866-019-1639-8 |
Ejemplares similares
-
Antiviral activity of PHA767491 against human herpes simplex virus in vitro and in vivo
por: Hou, Jue, et al.
Publicado: (2017) -
The interplay between human herpes simplex virus infection and the apoptosis and necroptosis cell death pathways
por: Yu, Xiaoliang, et al.
Publicado: (2016) -
Evasion of Early Antiviral Responses by Herpes Simplex Viruses
por: Suazo, Paula A., et al.
Publicado: (2015) -
Mitoxantrone dihydrochloride, an FDA approved drug, binds with SARS-CoV-2 NSP1 C-terminal
por: Kumar, Prateek, et al.
Publicado: (2022) -
Antiviral Activities of Officinaloside C against Herpes Simplex Virus-1
por: Xiao, Ji, et al.
Publicado: (2022)